Disease Areas of Collaborative Focus


In vitro  Assay Capabilities

BioModels has the expertise and capabilities to provide both in vivo and in vitro preclinical oncology models that are designed to enable the successful translation of potential anti-cancer drug candidates, biologics, and devices into human clinical trials. All of our oncology models can be customized to assess specific outcomes of interest.

In vitro screening assays can be used to quickly test compounds for their ability to inhibit tumor growth and limit invasive migration prior to testing in an in vivo setting. BioModels can provide programs to examine the impact of test compounds on tumorspheres and to co-model tumor stroma with other relevant cells or tissues. BioModels is also equipped with cell separation and FACS capabilities for further analysis of cell populations and drug responses.

Daniel Lichtman

Managing Partner